Thompson Jaye
SEC CIK 1476971 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GLSI | Greenwich LifeSciences, Inc. | VP Clinical Reg. Affairs | 264.1K | $164.8K | — | 21 | 2022-01-13 | 2024-11-21 |
Most active insiders at GLSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Snehal | CEO, CFO, Dir, 10% | $586.3K | — |
Thompson Jaye made no open-market trades at GLSI in the last 12 months.
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-21 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $12.91 | +1,000 | 264.1K | +0.4% | +$12.9K | |
| 2024-09-16 | 2024-08-12 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $13.85 | +800 | 263.1K | +0.3% | +$11.1K | |
| 2024-08-05 | 2024-08-02 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $15.15 | +1,000 | 262.3K | +0.4% | +$15.2K | |
| 2024-07-22 | 2024-07-18 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $16.00 | +1,000 | 261.3K | +0.4% | +$16.0K | |
| 2023-10-31 | 2023-10-27 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $8.57 | +500 | 260.3K | +0.2% | +$4,285 | |
| 2023-09-28 | 2023-09-26 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $8.71 | +600 | 259.8K | +0.2% | +$5,226 | |
| 2023-07-17 | 2023-07-13 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $9.49 | +250 | 259.2K | +0.1% | +$2,372 | |
| 2023-05-02 | 2023-04-28 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $11.22 | +250 | 259.0K | +0.1% | +$2,805 | |
| 2023-04-12 | 2023-04-11 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $11.87 | +1,000 | 258.7K | +0.4% | +$11.9K | |
| 2023-03-16 | 2023-03-15 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $12.71 | +250 | 257.7K | +0.1% | +$3,178 | |
| 2023-02-28 | 2023-02-24 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $15.40 | +250 | 257.5K | +0.1% | +$3,850 | |
| 2023-02-07 | 2023-02-03 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $20.84 | +250 | 257.2K | +0.1% | +$5,210 | |
| 2023-01-30 | 2023-01-27 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $19.20 | +250 | 257.0K | +0.1% | +$4,800 | |
| 2023-01-17 | 2023-01-13 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $16.50 | +250 | 256.7K | +0.1% | +$4,125 | |
| 2022-12-20 | 2022-12-16 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $12.94 | +250 | 256.5K | +0.1% | +$3,235 | |
| 2022-12-06 | 2022-12-02 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $13.98 | +250 | 256.2K | +0.1% | +$3,495 | |
| 2022-04-20 | 2022-04-19 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $16.74 | +500 | 256.0K | +0.2% | +$8,370 | |
| 2022-02-01 | 2022-01-31 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $18.47 | +500 | 255.5K | +0.2% | +$9,235 | |
| 2022-01-24 | 2022-01-21 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg Affairs | P - Purchase | $16.33 | +500 | 255.0K | +0.2% | +$8,165 | |
| 2022-01-19 | 2022-01-18 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg. Affairs | P - Purchase | $18.87 | +500 | 254.5K | +0.2% | +$9,435 | |
| 2022-01-14 | 2022-01-13 | GLSI | Greenwich LifeSciences, Inc. | Thompson Jaye | VP Clinical Reg. Affairs | P - Purchase | $19.99 | +1,000 | 254.0K | +0.4% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations